New Legislation Aims to Strengthen FDA Authority Over Dietary Supplements

What Does the New Supplement Legislation Propose?

The newly introduced legislation targets longstanding gaps in how the FDA oversees the dietary supplement industry. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplements are regulated more like foods than drugs — manufacturers do not need to prove safety or efficacy before bringing products to market. The new bill seeks to change this by requiring mandatory product listing with the FDA, giving regulators a comprehensive picture of what is actually being sold to consumers.

Key provisions include requiring manufacturers to register their products and ingredients with the FDA, strengthening adverse event reporting requirements, and giving the agency clearer authority to remove dangerous products from the market. Supporters argue these changes are long overdue given the explosive growth of the supplement industry, which has expanded from roughly 4,000 products in 1994 to an estimated 80,000 or more today, according to FDA estimates. The bill also addresses the rise of supplements sold online, which have been particularly difficult to regulate under existing law.

Why Has FDA Supplement Regulation Been So Limited?

The current regulatory landscape dates back to DSHEA, which was passed in 1994 after intense lobbying by the supplement industry and consumer advocacy groups who argued that vitamins and herbal products should remain accessible without prescription. Under DSHEA, supplements are presumed safe unless the FDA can prove otherwise — a standard that effectively reverses the burden of proof compared to pharmaceutical regulation. The FDA cannot require pre-market testing and must gather its own evidence of harm before taking enforcement action.

This framework has drawn increasing criticism from public health experts and physicians. The Government Accountability Office (GAO) and the FDA's own reports have repeatedly identified challenges with the current system, including difficulty tracking adverse events and limited resources for enforcement. High-profile cases of contaminated or adulterated supplements — including products found to contain undeclared pharmaceutical ingredients — have fueled calls for reform. Consumer advocacy organizations such as the Center for Science in the Public Interest have long supported stronger FDA oversight, while industry groups like the Council for Responsible Nutrition have expressed willingness to engage on mandatory product listing while cautioning against overly burdensome requirements.

How Could This Affect Consumers and the Supplement Industry?

For consumers, the legislation could mean greater confidence that the supplements they purchase have been registered with the FDA and meet baseline safety standards. A mandatory product listing system would allow regulators and the public to know exactly what products are on the market, making it easier to identify and recall problematic items. This is particularly relevant given that surveys suggest a majority of American adults report using dietary supplements, with the Council for Responsible Nutrition's annual survey consistently showing usage rates above 70 percent among US adults.

For the supplement industry, the changes would introduce new regulatory obligations that could increase compliance costs, particularly for smaller manufacturers. However, many established industry players have signaled support for a mandatory product listing requirement, viewing it as a way to distinguish legitimate companies from bad actors selling unsafe or fraudulently labeled products. The legislation's fate in Congress remains uncertain, as supplement regulation has historically been a politically sensitive topic with strong advocacy on both sides. Observers note that bipartisan support for the bill may improve its chances compared to previous reform efforts that failed to advance.